Activation of Vascular Endothelial Cell Adhesion Molecule Expression by Sickle Blood Cells

References

• Rothman S M, Fulling K, Nelson J S, et al. Sickle cell anemia and central nervous system infarction: a neuropathological study. Ann Neurol 1986; 20: 684–690
   PubMed Web of Science ®Google Scholar
• Francis R B. Large-vessel occlusion in sickle cell disease: pathogenesis, clinical consequences, and therapeutic implications. Med Hypotheses 1991; 35: 88–95
   PubMed Web of Science ®Google Scholar
• Faller D V. Vascular modulation. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Raven Press, New York 1994
   Google Scholar
• Hoover R, Rubin R, Wise G, Warren R. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures. Blood 1979; 54: 872–876
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Boogaerts M AB, Eaton J W, Steinberg M H. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanism for microvascular occlusion in sickle cell disease. N Engl J Med 1980; 302: 992
   PubMed Web of Science ®Google Scholar
• Barabino G A, McIntire L V, Eskin S G, Sears D A, Udden M. Endothelial cell interactions with sickle cell, sickle trait, mechanically injured, and normal erythrocytes under controlled flow. Blood 1987; 70: 152–157
   PubMed Web of Science ®Google Scholar
• Kaul D K, Fabry M E, Nagel R L. Microvascular site characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications. Proc Natl Acad Sci USA 1989; 86: 3356–3360
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Mohandas N. Sickle cell adherence. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Raven Press, New York 1994; 217–230
   Google Scholar
• Fabry M E, Fine E, Rajanayagam V, et al. Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable sickle cells discocytes. Blood 1992; 79: 1602–1611
   PubMed Web of Science ®Google Scholar
• Brittain H A, Eckman J R, Wick T M. Sickle erthrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 1992; 120: 538–545
   PubMed Web of Science ®Google Scholar
• Hebbel R P. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood 1991; 214–237
   Google Scholar
• Wick T M, Eckman J R. Molecular basis of sickle cell-endothelial cell interactions. Curr Opin Hematol 1996; 3: 118–124
   PubMedGoogle Scholar
• Osborn L, Hession C, Tizard R, et al. Direct expression and cloning of vascular cell adhesion molecule-1 (VCAM-I), a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203–1211
   PubMed Web of Science ®Google Scholar
• Swerlick R A, Lee K H, Lee L J, Sepp N T, Caughman S W, Lawley T J. Regulation of vascular cell adhesion molecule I on human dermal microvascular endothelial cells. J Immunol 1992; 149: 698–705
   PubMed Web of Science ®Google Scholar
• Thomson A PJ, Dick M. Endotoxinaemia in sickle cell disease. Clin Lab Haematol 1988; 10: 397–400
   Google Scholar
• Smolinski P A, Offermann M K, Eckman J R, Wick T M. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia. Blood 1995; 85: 2945–2950
   Google Scholar
• Stockman J A, Nigro M A, Mishkin M M, Oski F A. Occlusion of large cerebral vassels in sickle-cell anemia. N Engl J Med 1972; 287: 846–949
   PubMed Web of Science ®Google Scholar
• Wilimas J, Goff J R, Anderson H R, Langston J W, Thompson E. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr 1980; 96: 205–208
   PubMed Web of Science ®Google Scholar
• Samaik S, Sooiya D, Kim J, Ravindranath Y, Lusher J. Periodic transfusions for sickle cell anemia and CNS infarction. AJDC 1979; 133: 1254–1257
   Google Scholar
• Russell M O, Goldberg H I, Hodson A, et al. Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 1984; 63: 162–169
   PubMed Web of Science ®Google Scholar
• Zimmerman R A. MRI of sickle cell cerebral infarction. Neuroradiology 1987; 29: 232
   Google Scholar
• Adams R J, Nichols F T, McKie V, McKie K, Milner P, Gammal T E. Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology 1988; 38: 1012–1017
   PubMed Web of Science ®Google Scholar
• Oyesiku N M, Barrow D L, Eckman J R, Tindall S C, Colohan A R. Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis. J Neurosurg 1991; 75: 356–363
   PubMed Web of Science ®Google Scholar
• Sowemimo-Coker S O, Meiselman H J, Francis R B. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 1989; 31: 263–265
   PubMed Web of Science ®Google Scholar
• Solovey A, Lin Y, Brown P, Wayner E, Hebbel R P. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 1584–1590
   PubMed Web of Science ®Google Scholar
• Blei F, Barnes K, Guarini L. Elevated levels of circulating intercellular adhesion molecule-1 (cICAM-I) in sickle cell disease. Blood 1993; 82: 354a, (abstract)
   Google Scholar
• Saleh A W, Duits A J, Gerbers A, deVries C, Hillen H FP. Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy. Acta Haematol 1998; 100: 26–31
   PubMed Web of Science ®Google Scholar
• Bouvier C A, Gaynor E, Cintron J R, Bernhardt B, Spaet T H. Circulating endothelium as an indication of vascular injury. Thromb Diath Hemorrh 1970; 40: 163–168
   Google Scholar
• Koch A E, Shah M R, Harlow L A, Lovis R M, Pope R M. Soluble intercellular adhesion molecule-I in arthritis. Clin Immunol Immunopathol 1994; 71: 208–215
   PubMedGoogle Scholar
• Janssen B A, Luqmani R A, Gordon C, et al. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol 1994; 33: 1112–1116
   PubMedGoogle Scholar
• Neidhart M, Pataki F, Fehr K. Increased soluble endothelial adhesion molecules in rheumatoid arthritis correlate with circulating cytokines and depletion of CD45RO + T-lymphocytes from blood stream. Achweiz Med Wochenschr 1995; 125: 424–428
   Google Scholar
• Litwin M S, Gamble J R, Vadas M A. Role of cytokines in endothelial cell functions. Human Cytokines: Their Role in Disease and Therapy, B B Aggarwal, R K Puri. Blackwell Science, Cambridge 1995
   Google Scholar
• Carlos T M, Schwartz B R, Kovach N L, et al. Vascular cell adhesion molecule-I mediates lymphocyte adherence to cytokine activated cultured human endothelial cells. Blood 1990; 76: 965–970
   PubMed Web of Science ®Google Scholar
• Bevilacqua M P, Pober J S, Mendrick D L, Cotran R S, Gimbrone M A. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238–9242
   PubMed Web of Science ®Google Scholar
• Dustin M L, Rothlein R, Bhah A K, Dinarello C A, Springer T A. Induction by IL-I and interteron-g: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-I). J Immunol 1986; 137: 245–254
   PubMed Web of Science ®Google Scholar
• Bevilacqua M P. Endothelial-leukocyte adhesion molecules. Ann Rev Med 1993; 11: 767–804
   Google Scholar
• Pober J S, Cotran R S. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537–544
   PubMed Web of Science ®Google Scholar
• Bevilacqua M P, Nelson R M, Mannori G, Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Ann Rev Med 1994; 45: 361–378
   PubMed Web of Science ®Google Scholar
• Wautier J L, Pintigny D, Maclouf J, Wautier M P, Corvazier E, Carlos T M. Release of prostacyclin after erythrocyte adhesion to cultured vascular endothelium. J Lab Clin Med 1986; 107: 210–215
   Google Scholar
• Sowemimo-Coker S O, Haywood L J, Meiselman H JFRB. Effects of normal and sickle erythrocytes on prostacyclin release by perfused human umbilical cord veins. Am J Hematol 1992; 40: 276–282
   Google Scholar
• Mosseri M, Bartlett-Pandite A N, Wenc K, Isner J M, Weinstein R. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes. Am Heart J 1993; 126: 338–346
   PubMed Web of Science ®Google Scholar
• Phelan M, Perrine S P, Brauer M, Faller D V. Sickle erythrocytes, after sickling, regulate the expression of the endothelium-I gene and protein in human endothelial cells in culture. J Clin Invest 1995; 96: 1145–1151
   PubMed Web of Science ®Google Scholar
• Weinstein R, Zhou M, Bartlett-Pandite A N, Wenc K. Sickle erythrocytes inhibit human endothelial cell DNA synthesis. Blood 1990; 76: 2146–2152
   PubMed Web of Science ®Google Scholar
• Sherrill A W, Eckman J R, Wick T M, Nerem R M. Short-term contact with sickle erythrocytes inhibits shear-induced elongation of arterial endothelium. Blood 1994; 84: 407a, (abstract)
   Google Scholar
• Brown M D. Sickle cell endothelial: modulation of endothelial cell adhesion molecule expression. Georgia Institute of Technology, School of Chemical Engineering, Atlanta 1995
   Google Scholar
• Jaffee E A, Nachman R L, Becker C G, Minick C R. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. Br J Rheumatol 1973; 52: 2745–2756
   Google Scholar
• Gonzales R S. In vitro studies of monocyte adhesion to the endothelium under flow–implications on the progression of atherosclerosis. Georgia Institute of Technology, Atlanta 1995
   Google Scholar
• Lynn W A, Golenbock D T. Lipopolysaccharide antagonists. Immunology Today 1992; 13: 271–275
   PubMedGoogle Scholar
• Tran-Son-Tay R, Beaty B B, Coffey B E. Effects of ceU lysis on the rheological behavior red blood ceU suspensions. J Biomechan Eng 1990; 112: 257–262
   Google Scholar
• Bate C A, Kwiatkowski D P. Stimulators of tumour necrosis factor production released by damaged erythrocytes. Immunology 1994; 83: 256–261
   Google Scholar
• Beutler E, West C, Blume K G. The removal of leukocytes and platelets from whole blood. J Lab Clin Med 1976; 88: 328–333
   PubMed Web of Science ®Google Scholar
• Boyle W. An extension of the 51Cr-release assay for the estimation of mouse cytotoxins. Transplantation 1968; 6: 761–764
   PubMed Web of Science ®Google Scholar
• Martin W J, Finerty J, Rosenthal A. Isolation of plasmodium berghie (malaria) parasites by ammonium chloride lysis of infected erythrocyte. Nature (New Biol) 1971; 233: 260–261
   PubMedGoogle Scholar
• Hassard T H. Understanding biostatistics. Mosby–Year Book, St Louis 1991
   Google Scholar
• Vadas M A, Gamble J R, Wsmith B. Regulation of myeloid blood ceUendothelial interaction by cytokines. Adhesion: Its Role in Inflammatory Disease, J M Harlan, D Y Liu. Freeman and Company, New York 1992
   Google Scholar
• Francis R B, Haywood L J. Elevated immunoreactive tumor necrois factor and interleukin-I in sickle cell disease. J Natl Med Assoc 1992; 84: 611–615
   PubMed Web of Science ®Google Scholar
• Malave I, Perdomo Y, Escalona E, et al. Levels of tumor necrosis factor a/cachetin (TNFa) in sera from patients with sickle cell disease. Acta Haematol 1993; 90: 172–176
   PubMed Web of Science ®Google Scholar
• Croizat H. Circulating cytokines in sickle cell patients during steady state. Br J Haematol 1994; 87: 592–597
   PubMed Web of Science ®Google Scholar
• Aggarwal B B. Human cytokines: their role in disease and therapy. Blackwell Science, Cambridge 1995
   Google Scholar
• Dinarello C A. Interleukin-I and interleukin-I antagonism. Blood 1991; 7: 1627–1652
   Google Scholar
• Klug P P, Kaye N, Jensen W N. Endothelial cell and vascular damage in the sickle cell disorders. Blood Cells 1982; 8: 175–184
   PubMedGoogle Scholar
• Duits A J, Pieters P C, Saleh A W, van Rosmalen E, Rojer R A. Soluble VCAM-1 levels in symptomatic and asymptomatic sickle cell patients. Clin Immunol Immunopathol 1996; 81: 96–98
   PubMedGoogle Scholar
• Malave I, Escalona E, Perdomo Y, Pocino M, Malave D, Arends T. In vitro antibody synthesis by peripheral blood mononuclear cells from patients with sickle cell disease. Acta Haematol 1990; 84: 89–94
   Google Scholar
• Longenecker G L, Beyers B J, Mankad V N. Platelet regulatory prostanoids and platelet release products in sickle cell disease. Am J Hematol 1992; 40: 12–19
   PubMed Web of Science ®Google Scholar
• Balkaran B, Char G, Morris J S, Thomas P W, Serjeant B E, Serjeant G R. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360–366
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner S J, Sleeper L A. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998; 91: 288–294
   PubMed Web of Science ®Google Scholar
• Mansour M A. A severity profile of possible determinants of mortality in adult sickle cell anemia. University of Illinois at Chicago. 1986
   Google Scholar
• Lipowsky H H, Chien S. Role of leukocyte-endothelium adhesion in affecting recovery from ischemic episodes. Ann NY Acad Sci 1989; 565: 308–315
   PubMed Web of Science ®Google Scholar
• Platt O S, Brambilla D J, Rosse W F, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639–1644
   PubMed Web of Science ®Google Scholar
• Miller S T, Sleeper L A, Pegelow C H, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000; 342: 83–89
   PubMed Web of Science ®Google Scholar
• Charache S, Barton F B, Moore R D, et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. Medicine 1996; 75: 300–324
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Boogaerts M A, Eaton J W, Steinberg M H. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med 1980; 302: 992–995
   PubMed Web of Science ®Google Scholar
• Hebbel R P. Membrane-associated iron. Sickle Cell Disease: Basic Principles and Clinical Practice, S H Embury, R P Hebbel, N Mohandas, M H Steinberg. Raven Press, New York 1994
   Google Scholar
• Kumar A, Eckman J R, Swerlick R A, Wick T M. Phorbol ester stimulation increases sickle erythrocyte adherence to endothelium: a novel pathway involving α4/β1 integrin receptors on sickle reticulocytes and fibronectin. Blood 1996; 88: 4348–4358
   PubMed Web of Science ®Google Scholar
• Wick T M, Moake J L, Udden M M, Eskin S G, Sears D A. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. J Clin Invest 1987; 80: 905–910
   PubMed Web of Science ®Google Scholar
• Swerlick R A, Eckman J R, Kumar A, Jeitler M, Wick T. Alpha-4/beta-1 integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1 dependent binding to endothelium. Blood 1993; 82: 1891–1899
   PubMed Web of Science ®Google Scholar
• Harlan J M, Winn R K, Vedder N B, Doerschuk C M, Rice C L. In vivo models of leukocyte adherence to endothelium. Adhesion: Its Role in Inflammatory Disease, J M Harlan, D Y Liu. Freeman and Company, New York 1992
   Google Scholar
• Frenette P S, Wagner D D. Adhesion molecules–Part I. N Engl J Med 1996; 334: 1526–1529
   PubMed Web of Science ®Google Scholar
• Frenette P S, Wagner D D. Adhesion molecules–Part II. N Engl J Med 1996; 334: 43–45
   Google Scholar